Clean ClAImsFirst Pass

CoverMyMeds (McKesson) vs Develop Health

Two Prior Authorization vendors, side by side. Facts from public sources; judgments are ours.

At a glance

Derived from public facts · a rough scale, not a ranking

CoverMyMeds (McKesson)Develop Health
Pricing model

Free to providers (funded by payers/pharma) · Payers, PBMs, pharma fund the network

Free to providers (funded by payers/pharma) · pharma-funded, free for prescribers

Speed to go live

Free self-serve portal; EHR-embedded options exist

API integration into existing EHR workflow

Automation model

Data / network utility · medication ePA network and portal

Autonomous agents · automated benefit checks and PA submission

Built for

Small practices, Mid-size groups, Enterprise systems, Payers

Small practices, Mid-size groups, Enterprise systems

Security posture

No certifications published

HIPAA

Company maturity

18 yrs (est. 2008)

4 yrs (est. 2022)

Financial backing

Subsidiary of McKesson

$17.6M · Series A

Named customers

None public

4 named

Published results

No public numbers

No public numbers

Documented integrations

5 listed

2 listed

Third-party validation

None found

None found

Bottom line

  • Pick CoverMyMeds if you want free electronic prior auth for medications with the broadest payer and pharmacy network.
  • Pick Develop Health if medication prior auths bottleneck your prescribers and you want end-to-end PA automation at no cost to the practice.

CoverMyMeds (McKesson)

The largest electronic prior authorization network for medications

Founded
2008
HQ
Columbus, OH
Stage
Subsidiary of McKesson
Raised
n/a

What it does

  • Electronic prior authorization for retail and specialty drugs
  • Specialty enrollment and hub services (RxLightning)
  • Medical benefit PA for oncology and radiology (FastAuth)
  • Benefit checks and prescription price transparency
  • Patient affordability and copay program delivery

Where it's strong

  • Network effects are real: it completed 43 million prior authorizations in the 2025 reverification season and most prescribers already have accounts.
  • Free for providers and pharmacies, which makes adoption easy.
  • McKesson ownership ties it into specialty distribution and pharma services that competitors cannot match.

What buyers should weigh

  • Coverage is payer-dependent and shifting: Independence Blue Cross dropped CoverMyMeds for Surescripts ePA in August 2025, so verify your payer mix routes through it.
  • It centers on medication PA; medical benefit and procedure prior auth needs mostly require other tools despite the FastAuth acquisition.
  • Its revenue comes from pharma and payers, so provider-side feature priorities can lag.

Integrations

EpicOracle Health (Cerner)Hundreds of EHRsPharmacy management systemsPayers and PBMs
Full CoverMyMeds (McKesson) profile →

Develop Health

AI benefit verification and prior auth for prescriptions

Founded
2022
HQ
Menlo Park, CA
Stage
Series A
Raised
$17.6M

What it does

  • Real-time benefit verification with plan-specific cost and coverage
  • Predicts coverage and PA requirements at point of prescription
  • Generates and submits prescription prior authorization packages
  • Drafts appeals and manages denials automatically
  • Returns structured coverage data into the prescriber's EHR

Where it's strong

  • Purpose-built for prescription drug access (benefit checks plus medication PA), a narrower and deeper wedge than general prior auth vendors.
  • Named traction with high-volume telehealth prescribers like Ro and LifeMD, where GLP-1 coverage friction makes the ROI easy to measure.
  • Founders came from Canvas Medical and Rupa Health, so the product is built around real prescriber workflow integration rather than a standalone portal.

What buyers should weigh

  • Total funding of $17.6 million and a 2022 founding date make this an early-stage vendor bet; assess team depth and support model before committing core volume.
  • Public proof points are concentrated in telehealth and virtual care companies, so traditional health systems and pharmacies will find fewer reference customers.
  • Scope is medications only; if you also need procedure, imaging, or DME prior auth, you will still need another vendor.

Named customers

Ro · LifeMD · Calibrate · Sunrise

Integrations

EHRs (API integration into prescriber workflows)Pharmacy benefit managers
Full Develop Health profile →

Compare against the rest of Prior Authorization

Deciding between these two?

First Pass tracks Prior Authorization every week: funding, launches, and what changed since this page was written.